X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AMAR REMEDIES with JYOTHY LABS - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs JYOTHY LABS - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES JYOTHY LABS AMAR REMEDIES/
JYOTHY LABS
 
P/E (TTM) x -0.5 15.2 - View Chart
P/BV x 0.1 2.6 2.4% View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 AMAR REMEDIES   JYOTHY LABS
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
JYOTHY LABS
Mar-18
AMAR REMEDIES/
JYOTHY LABS
5-Yr Chart
Click to enlarge
High Rs164441 37.2%   
Low Rs86325 26.5%   
Sales per share (Unadj.) Rs261.696.0 272.4%  
Earnings per share (Unadj.) Rs17.49.8 176.8%  
Cash flow per share (Unadj.) Rs22.311.6 192.9%  
Dividends per share (Unadj.) Rs00.50 0.0%  
Dividend yield (eoy) %00.1 0.0%  
Book value per share (Unadj.) Rs100.762.9 160.0%  
Shares outstanding (eoy) m26.16181.79 14.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.54.0 12.0%   
Avg P/E ratio x7.238.9 18.5%  
P/CF ratio (eoy) x5.633.2 16.9%  
Price / Book Value ratio x1.26.1 20.4%  
Dividend payout %05.1 0.0%   
Avg Mkt Cap Rs m3,27069,626 4.7%   
No. of employees `000NA2.6 0.0%   
Total wages/salary Rs m1631,908 8.5%   
Avg. sales/employee Rs ThNM6,751.2-  
Avg. wages/employee Rs ThNM737.9-  
Avg. net profit/employee Rs ThNM691.7-  
INCOME DATA
Net Sales Rs m6,84417,459 39.2%  
Other income Rs m21491 4.3%   
Total revenues Rs m6,86517,950 38.2%   
Gross profit Rs m1,1312,708 41.8%  
Depreciation Rs m128311 41.1%   
Interest Rs m398481 82.8%   
Profit before tax Rs m6262,407 26.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-500-   
Tax Rs m121619 19.6%   
Profit after tax Rs m4551,789 25.4%  
Gross profit margin %16.515.5 106.5%  
Effective tax rate %19.325.7 75.2%   
Net profit margin %6.610.2 64.9%  
BALANCE SHEET DATA
Current assets Rs m4,9046,628 74.0%   
Current liabilities Rs m3,5818,129 44.1%   
Net working cap to sales %19.3-8.6 -224.8%  
Current ratio x1.40.8 168.0%  
Inventory Days Days12439 315.6%  
Debtors Days Days10034 298.0%  
Net fixed assets Rs m1,68911,060 15.3%   
Share capital Rs m262182 144.1%   
"Free" reserves Rs m2,35811,260 20.9%   
Net worth Rs m2,63511,442 23.0%   
Long term debt Rs m50738 1,344.8%   
Total assets Rs m6,86219,790 34.7%  
Interest coverage x2.66.0 42.8%   
Debt to equity ratio x0.20 5,839.7%  
Sales to assets ratio x1.00.9 113.1%   
Return on assets %12.411.5 108.4%  
Return on equity %17.315.6 110.5%  
Return on capital %31.025.2 123.2%  
Exports to sales %4.00-   
Imports to sales %00-   
Exports (fob) Rs m273NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m273144 190.0%   
Fx outflow Rs m2340 0.6%   
Net fx Rs m271-196 -138.2%   
CASH FLOW
From Operations Rs m-3132,435 -12.8%  
From Investments Rs m-489-753 64.8%  
From Financial Activity Rs m769-1,453 -52.9%  
Net Cashflow Rs m-33228 -14.2%  

Share Holding

Indian Promoters % 25.5 66.8 38.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 9.2 8.4 109.0%  
FIIs % 0.0 14.5 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 10.3 634.0%  
Shareholders   13,061 84,983 15.4%  
Pledged promoter(s) holding % 99.7 36.7 271.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   GODREJ CONSUMER  KARUTURI GLOBAL  K.S.OILS LTD  BAJAJ CONSUMER CARE  MARICO  

Compare AMAR REMEDIES With:   P&G (US)  UNILEVER PLC. (UK)  HYPERMARCAS (Brazil)  



Today's Market

Sensex Ends 160 Points Higher; IT and Healthcare Stocks Witness Buying(Closing)

Indian share markets traded on a positive note most of the day and ended higher. Gains were largely seen in the IT sector and healthcare sector, while capital goods stocks witnessed selling pressure.

Related Views on News

JYOTHY LABS Announces Quarterly Results (4QFY19); Net Profit Up 11.1% (Quarterly Result Update)

May 8, 2019 | Updated on May 8, 2019

For the quarter ended March 2019, JYOTHY LABS has posted a net profit of Rs 670 m (up 11.1% YoY). Sales on the other hand came in at Rs 5 bn (down 0.2% YoY). Read on for a complete analysis of JYOTHY LABS's quarterly results.

JYOTHY LABS Announces Quarterly Results (3QFY19); Net Profit Up 47.1% (Quarterly Result Update)

Jan 24, 2019 | Updated on Jan 24, 2019

For the quarter ended December 2018, JYOTHY LABS has posted a net profit of Rs 484 m (up 47.1% YoY). Sales on the other hand came in at Rs 4 bn (up 0.7% YoY). Read on for a complete analysis of JYOTHY LABS's quarterly results.

JYOTHY LABS Announces Quarterly Results (2QFY19); Net Profit Down 4.7% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, JYOTHY LABS has posted a net profit of Rs 453 m (down 4.7% YoY). Sales on the other hand came in at Rs 4 bn (down 0.5% YoY). Read on for a complete analysis of JYOTHY LABS's quarterly results.

JYOTHY LABS Announces Quarterly Results (1QFY19); Net Profit Up 33.3% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, JYOTHY LABS has posted a net profit of Rs 324 m (up 33.3% YoY). Sales on the other hand came in at Rs 4 bn (up 5.0% YoY). Read on for a complete analysis of JYOTHY LABS's quarterly results.

JYOTHY LABS Announces Quarterly Results (4QFY18); Net Profit Down 30.1% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, JYOTHY LABS has posted a net profit of Rs 760 m (down 30.1% YoY). Sales on the other hand came in at Rs 5 bn (up 10.9% YoY). Read on for a complete analysis of JYOTHY LABS's quarterly results.

More Views on News

Most Popular

I Believe this is the Best Stock to Buy Today(Profit Hunter)

Jul 3, 2019

The languishing small cap space is currently offering a very fertile market to pick up bargains at very attractive prices. This is a perfect opportunity ripe for the picking.

This Smallcap Stock could be the next Page Industries(Profit Hunter)

Jul 2, 2019

The smallcap rebound is taking longer to play out...and that's good news as it gives you more of action time and opportunities to invest in.

The Indian Rating Agency Cleanup Has Begun and this Cheap Stock Could be the Best Bet(The 5 Minute Wrapup)

Jul 2, 2019

The last time this big rating agency was as cheap and out-of-favour as it is today, the stock had corrected by 40% in six months.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 5-YR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS